Ensuring Kawasaki Disease won’t be a marginalized pediatric illness!

Researcher

Preeti Jaggi, MD
Dr. Jaggi is an Assistant Professor of Pediatrics in the Division of Infectious Diseases at The Ohio State University (Nationwide Children’s Hospital). She has several publications in the field of streptococcal research and has been successful in receiving grants for her work (2003 and 2007) for her streptococcal research and for research on patients with chronic granulomatous disease. More recently, Dr. Jaggi’s focus has been on Kawasaki disease. She has been participating in a randomized, double blind placebo controlled with Drs. Burns and Tremoulet from San Diego Rady Children’s Hospital studying the benefit of adding infliximab to standard primary treatment for Kawasaki disease. She currently follows all the Kawasaki patients diagnosed at Nationwide Children’s Hospital during their acute illness as well as during follow-up. In the past years, she has been maintaining a clinical research database of all Kawasaki patients since 2009 from which to draw upon for further research. Dr. Jaggi recently received an American Heart Association grant, “Gene Expression Profiles for Improving the Diagnosis of Kawasaki Disease” awarded Jan 1, 2011.